Ex Parte Mizuno et al - Page 5

                Appeal 2006-0886                                                                                  
                Application 10/151,093                                                                            
                formulation of a breaker and in concentrations overlapping the claimed                            
                concentrations.  That the prior art discloses a multitude of effective                            
                combinations does not render any particular formulation less obvious.                             
                Merck & Co. v. Biocraft Labs., 874 F.2d 804, 807, 10 USPQ2d 1843, 1846                            
                (Fed. Cir.), cert. denied, 493 U.S. 975 (1989).  Nor is the presence of other                     
                additives such as polysulfide foreclosed by Appellants’ claim 1.  The word                        
                “comprising” opens claim 1 to the presence of such other additives. Nor, in                       
                the present case, is the genus of possible combinations all that much larger                      
                than the genus encompassed by the claims.  The selection, for instance, of a                      
                silica filler from a list of silica, aluminosilicates, zeolites and/or carbon black               
                is hardly unobvious.  In fact, Appellants’ composition may also contain a                         
                very large number of additives.  Given the knowledge of those of ordinary                         
                skill in the art, such knowledge being evidenced by Lickes, it would have                         
                been obvious to select a combination of additives including those recited in                      
                claim 1 for use in a rubber composition to form a breaker.                                        
                       Nor can we agree that Lickes must state that resorcinol and a                              
                methylene donor are essential additives to establish a prima facie case of                        
                obvious (Br. 7).  It is enough that Lickes suggests the inclusion of these                        
                additives with the other additives discussed in the reference.                                    
                       Nor can we agree with Appellants that the fact that the working                            
                examples of Lickes exemplify different compositions from that claimed                             
                somehow negates the teachings of the broader disclosure (Br. 8).  A                               
                reference may be relied upon for all that it would have reasonably suggested                      
                to one having ordinary skill in the art, including non-preferred embodiments.                     
                Merck & Co v. Biocraft Labs., 874 F.2d 804, 807, 10 USPQ2d 1843, 1847                             
                (Fed. Cir. 1989).  Disclosed examples and preferred embodiments do not                            

                                                        5                                                         


Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007